Dealmaking in Europe’s life sciences sector has been relatively muted in recent years, but the first half of 2025 has shown signs of strength as companies respond to the stark realities of an aging population -
Earlier this...more
7/23/2025
/ Acquisitions ,
Artificial Intelligence ,
EU ,
European Commission ,
Healthcare ,
Life Sciences ,
Mergers ,
Pharmaceutical Industry ,
Popular ,
Private Equity ,
Technology
Artificial intelligence (AI) is increasingly transforming business processes and strategies across industry sectors. Companies are figuring out how to take advantage of AI, focusing primarily on customers' needs and...more
11/19/2020
/ Artificial Intelligence ,
Big Data ,
Board of Directors ,
Business Judgment Rule ,
Corporate Governance ,
Decision-Making Process ,
Duty of Care ,
Fiduciary Duty ,
Machine Learning ,
Risk Management ,
Technology